Q4 2018

Filed Feb 27, 2019 · 10-K · 58 days after period end · 0001564590-19-004979

Q4 2018 · 10-K

derived · Computed from the longer spans the company filed.

Revenue

$108.05M

derived+251.6% vs Q4 2017

Net Income

$20.95M

derivedN/M vs Q4 2017

EPS, diluted—

Same quarter

Metric	Q4 2018derived from reported figures	Q4 2017derived from reported figures	Q4 2016derived from reported figures	Q4 2015derived from reported figures
Revenue	$108.05M	$30.74M	$35.53M	$24.44M
Net Income	$20.95M	-$33.89M	-$30.39M	-$51.37M

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Kyntra Bio, Inc. · CIK 921299 · Engraved from SEC EDGAR